Galectin Therapeutics
Galectin Sciences LLC is a collaborative venture between Galectin Therapeutics Inc. and SBH Sciences Inc. The company focuses on researching and developing small organic molecule inhibitors of galectin-3 for oral administration. Galectin Sciences aims to identify and develop highly specific galectin inhibitors as potential treatment options for diseases such as fibrosis and cancer, where galectins play a significant role.
With Galectin Therapeutics' expertise in galectin proteins and SBH Sciences' knowledge in cell-based assays and biological activity, Galectin Sciences combines scientific understanding and molecular modeling techniques to discover and develop drug candidates. The long-term goal of the company is to develop small molecule inhibitors of galectin-3 that exhibit activity in preclinical disease models, ultimately expanding treatment approaches for inflammatory, fibrotic, and neoplastic diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
